Eltrombopag Tablet, Film Coated
Product Images NDC 72865-302

5 FDA label images from Xlcare Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 72865-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eltrombopagstructure (Eltrombopagstructure)

Eltrombopagstructure (Eltrombopagstructure)
Chemical structure diagram of eltrombopag, depicting its molecular composition including aromatic rings, amide, hydroxyl, and amino groups, as well as a dihydrate component shown as two molecules of HO-CH2-CH2-NH2.*
FDA Label Image

Eltrombopag125mgcontainerlabel (Eltrombopag125mgcontainerlabel)

FDA Label Image

Eltrombopag25mgcontainerlabel (Eltrombopag25mgcontainerlabel)

FDA Label Image

Eltrombopag50mgcontainerlabel (Eltrombopag50mgcontainerlabel)

FDA Label Image

Eltrombopag75mgcontainerlabel (Eltrombopag75mgcontainerlabel)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.